国立がん研究センターMDT　大腸がん治療戦略　Vol.1

出版社： 医学と看護社
著者：
発行日： 2013-10-25
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784906829286
電子書籍版： 2013-10-25 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,300 円(税込)

購入する

商品紹介

ガイドラインに記載のないケースにどう対処するか、もうひとつの癌治療ガイド、創刊！

目次

  • 国立がん研究センターMDT　大腸がん治療戦略　Vol.1

    ―目次―

    1．外科治療・局所治療
    2．化学療法（切除可能病変）
    3．化学療法（境界・再発病変）
    4．画像診断

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

MDTミーティング実行プロセスのポイント

P.7 掲載の参考文献
1) Kane B : An analysis of multidisciplinary medical team meeting dynamics. LAP LAMBERT Academic Publishing AG & CO. KG 2010
 
2) Rubenstein LZ, Josephson KR, Wieland GD, et al : Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med 1984 ; 311 : 1664-1670
 
3) Junor EJ, Hole DJ, Gillis CR : Management of ovarian cancer : referral to a multidisciplinary team matters. Br J Cancer 1994 ; 70 : 363-370
 
4) Ruhstaller T, Roe H, Thurlimann B, Nicoll JJ : The multidisciplinary meeting : An indispensable aid to communication between different specialities. Eur J Cancer 2006 ; 42 : 2459-2462
 

1. 外科治療・局所治療

P.13 掲載の参考文献
1) Akiyoshi T, Watanabe T, Miyata S, et al : Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer : is it regional or distant disease? Ann Surg 2012 ; 255:1129-1134
 
2) Fujita S, Yamamoto S, Akasu T, et al : Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis. Hepatogastroenterology 2012 ; 59 : 2494-2497
 
3) Sato H, Maeda K, Maruta M : Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma. Int J Colorectal Dis 2012 ; 59 : 2494-2497
 
4) Ueno M, Oya M, Azekura K, et al : Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005 ; 92 : 756-763
 
5) MERCURY Study Group, Shihab OC, Taylor F, Bees N, et al : Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg 2011 ; 98 : 1798-1804
 
6) Akasu T, Iinuma G, Takawa M, et al : Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol 2009 ; 16 : 2787-2794
 
7) Fujita S, Akasu T, Mizusawa J, et al : Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectalcancer (JCOG0212) : results from a multicentre, randomised controlled,non-inferiority trial. Lancet Oncol 2012 ; 13 : 616-621
PubMed
8) ASCRS Symposium on Contaract. IOL and Refractive Surgery. Chicago 2012 April : 20-24
 
P.16 掲載の参考文献
1) Sauer R, Liersch T, Merkel S, et al : Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer : results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012 ; 30 : 1926-1933
 
2) Folkesson J, Birgisson H, Pahlman L, et al : Swedish Rectal Cancer Trial : long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005 ; 23 : 5644-5650
 
3) Nagawa H, Muto T, Sunouchi K, et al : Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 2001 ; 44 : 1274-1280
 
4) Kim TH, Jeong SY, Choi DH, et al : Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008 ; 15 : 729-737
 
P.19 掲載の参考文献
1) Bismuth H, Castaing D, Traynor O : Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol Suppl 1988 ; 149 : 144-149
PubMed
2) Scheele J : Hepatectomy for liver metastases. Br J Surg 1993 ; 80 : 274-276
 
3) Nordlinge B, Sorbye H, Glimelius B, et al : EORTC liver metastases intergroup randomized phase III study 40983 : Long-term survival results. J Clin Oncol 2012 ; 30 (Suppl ; abstr 3508)
 
P.22 掲載の参考文献
1) Kobayashi K, Kawamura M, Ishihara T : Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg 1999 ; 118 : 1090-1096
 
2) Shah SA, Haddad R, AI-Sukhnlw, et al : Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006 ; 202 : 468-475
 
3) Miller G, Biernacki P, Kemeny NE, et al : Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 2007 ; 205 : 231-238
PubMed
4) 服部憲史, 金光幸秀, 小森康司, 他 : 大腸癌肝・肺転移切除症例の検討-肺転移単独と肝肺 2 臓器転移との比較-. 癌の臨床 2011 ; 56 : 789-796
 
5) Sakamoto Y, Sakaguchi Y, Oki E, et al : Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer. World J Surg 2012 ; 36 : 2708-2713
 
P.25 掲載の参考文献
1) 遺伝性大腸癌診療ガイドライン 2012年版, 大腸癌研究会編, 2012
 
2) Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, et al : Revised guidelines for the clinical management of Lynch syndrome (HNPCC) : recommendations by a group of European experts. Gut 2013 ; 0 : 1-13
 
P.28 掲載の参考文献
1) Min BS, Kim NK, Sohn SK, et al : Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol 2008 ; 97 : 136-140
 
2) Choi PW, Kim HC, Kim AY, et al : Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol 2010 ; 101 : 66-71
 
3) Pulitano C, Bodingbauer M, Aldrighetti L, et al : Liver resection for colorectal metastases in presence of extrahepatic disease : results from an international multi-institutional analysis. Ann Surg Oncol 2011 ; 18 : 1380-1388
 
P.32 掲載の参考文献
1) Benoist S, Brouquet A, Penna C, et al : Complete Response of Colorectal Liver Metastases After Chemotherapy : Does It Mean Cure? J Clin Oncol 2006 ; 24 : 3939-3945
 
2) Tournigand C, Cervantes A, Figer A,et al : OPTIMOX1 : A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer-a GERCOR Study. J Clin Oncol 2006 ; 24 : 394-400
 
3) Koopman M, et al : Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC) : The phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG). J Clin Oncol 2013 ; 31 (Suppl ; abstr 3502)
 
4) Chibaudel B, Maindrault-Goebel F, Lledo G, et al : Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study. J Clin Oncol 2009 ; 27 : 5727-5733
 
5) Grothey A, Sugrue MM, Purdie DM, et al : Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer : Results From a Large Observational Cohort Study (BRiTE). J Clin Oncol 2008 ; 26 : 5326-5334
 
P.35 掲載の参考文献
1) Tournigand C, Andre T, Achille E, et al : FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer : a randomized GERCOR study. J Clin Oncol 2004 ; 22 : 229-237
PubMed
2) Goere D, Daveau C, Elias D, et al : The differential response to chemotherapy of ovarian metastases from colorectal carcinoma. Eur J Surg Oncol 2008 ; 34 : 1335-1339
 
3) Kim DD, Park IJ, Kim HC, et al : Ovarian metastases from colorectal cancer : a clinicopathological analysis of 103 patients. Colorectal Dis 2009 ; 11 : 32-38
 
P.38 掲載の参考文献
1) Zhang C, Chen Y, Xue H, et al : Diagnostic value of FDG-PET in recurrent colorectal carcinoma : A meta-analysis. Int J Cancer 2009 ; 124 : 167-173
 
2) Moriya Y, Akasu T, Fujita S, et al : Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004 ; 4712 : 2047-2053
 
3) Hartley JE, Lopez RA, Paty PB, et al : Resection of locally recurrent colorectal cancer in the presence of distant metastases : can it be justified? Ann Surg Oncol 2003 ; 10 : 227-233
 
P.41 掲載の参考文献
1) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Anals of Oncology 2012 ; 23 : 2479-2516
 
P.45 掲載の参考文献
1) Ikematsu H, Yoda Y, Matsuda T, et al : Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterol 2013 ; 144 : 551-559
 
P.49 掲載の参考文献
1) 藤井隆広 : 国立がんセンター 大腸内視鏡診断アトラス 東京, 医学書院, 2004
 
2) Matsuda T, Fujii T, Saito Y, et al : Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008 ; 103 : 2700-2706
 
3) Saito Y, Uraoka T, Yamaguchi Y, et al : A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc 2010 ; 72 : 1217-1225
 

2. 化学療法 ( 切除可能病変 )

P.52 掲載の参考文献
1) O'Connor ES, Greenblatt DY, LoConte NK, et al : Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 2011 ; 29 : 3381-3388
 
2) Gunderson LL, Jessup JM, Sargent DJ, et al : Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010 ; 28 : 264-271
 
3) Benson AB 3rd, Schrag D, Somerfield MR, et al : American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004 ; 22 : 3408-3419
 
4) van Cutsem EJ, Oliveira J : ESMO Guidelines Working Group. Colon cancer : ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2008 ; 19 Suppl 2 : ii29-30
 
5) Aalok K, Hagen FK, Howard JL, et al : Use of adjuvant chemotherapy (AC) and outcomes in stage II colon cancer (CC) with versus without poor prognostic features. J Clin Oncol 30 : 2012 (Suppl 34 ; abstr 338)
 
P.57 掲載の参考文献
1) Nakagoe T, Yamaguchi E, Tanaka K, et al : Distal intramural spread is an independent prognostic factor for distant metastasis and poor outcome in patients with rectal cancer : a multivariate analysis. Ann Surg Oncol 2003 ; 10 : 163-170
 
2) Shirouzu K, Isomoto H, Kakegawa T : Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 1995 ; 76 : 388-392
 
3) 長谷和生 : 直腸癌先進部のbiological attitudeを示す組織学的所見の予後規定因子としての意義に関する研究. 日外会誌 1993 ; 94 : 1022-1152
 
P.60 掲載の参考文献
1) Akasu T, Moriya Y, Ohashi Y, et al : Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy : a multicenter randomized controlled trial. Jpn J Clin Oncol 2006 ; 36 : 237-244
 
2) Akiyoshi T, Watanabe T, Miyata S, et al : Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal Cacer. Ann Surg 2012 ; 255 : 1129-1134
 
P.63 掲載の参考文献
1) Nordlinger B, Sorbye H, Glimelius B, et al : Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983) : a randomised controlled trial. Lancet 2008 ; 371 : 1007-1016
 
2) Nordlinger B, Sorbye H, Glimelius B, et al : EORTC liver metastases intergroup randomized phase III study 40983 : Long-term survival results. J Clin Oncol 30, 2012 (Suppl ; abstr 3508)
 

3. 化学療法 ( 境界・再発病変 )

P.66 掲載の参考文献
1) Sugarbaker PH : Peritonectomy procedures. Ann Surg 1995 ; 221 : 29-42
 
2) Glehen O, Kwiatkowski F, Sugarbaker PH, et al : Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer : a multi-institutional study. J Clin Oncol 2004 ; 22 : 3284-3292
 
3) Verwaal VJ, van Ruth S, de Bree E, et al : Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003 ; 21 : 3737-3743
 
4) Gilly FN, Beaujard A, Glehen O, et al : Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis : phase I-II study. Anticancer Res 1999 ; 19 : 2317-2321
 
5) Jacquet P, Sugarbaker PH : Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996 ; 82 : 359-374
 
P.69 掲載の参考文献
1) 大腸・肛門外科, 武藤徹一郎編, 朝倉書店, 東京 1999, p311-312
 
2) Greenall MJ, Magill GB, Quan SH, et al : Recurrent epidermoid cancer of the anus. Cancer 1986 ; 57 : 1437-1441
 
3) Papillon J, Mayer M, Montbarbon JF, et al : A new approach to the management of epidermoid carcinoma of the anal canal. Cancer 1983 ; 51 : 1830-1837
 
4) Sauer I, Bacon HE : Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951 ; 81 : 111-120
 
5) Tocchi A, Lepre L, Costa G, et al : Rectal cancer and inguinal metastases : prognostic role and therapeutic indications. Dis Colon Rectum 1999 ; 42 : 1464-1466
 
6) Luna-Perez P, Corral P, Labastida S, et al : Inguinal lymph node metastases from adenocarcinoma. J Surg Oncol 1999 ; 70 : 177-180
 
P.72 掲載の参考文献
1) Biagi JJ, Raphael MJ, Mackillop WJ, et al : Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer : a systematic review and meta-analysis. JAMA 2011 ; 305 : 2335-2342
 
2) Flanagan FL, Dehdashti F, Ogunbiyi OA, et al : Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998 ; 227 : 319-323
 
3) Libutti SK, Alexander HR Jr, Choyke P, et al : A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 2001 ; 8 : 779-786
 
4) Nakamoto Y, Sakamoto S, Matsumoto K, et al : Factors related to positive PET findings in patients with high CEA levels. J Nucl Med 2002 ; 5 (Suppl) : 26-27
 
5) Berger KL, Nicholson SA, Dehdashti F, et al : FDG PET evaluation of mucinous neoplasms : correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000 ; 174 : 1005-1008
 
P.75 掲載の参考文献
1) Go PH, Klaassen Z, Meadows MC, et al : Gastrointestinal cancer and brain metastasis : a rare and ominous sign. Cancer 2011 ; 117 : 3630-3640
 
2) Lin NU, Bellon JR, Winer EP : CNS metastases in breast cancer. J Clin Oncol 2004 ; 22 : 3608-3617
 
3) Gaspar L, Scott C, Rotman M, et al : Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997 ; 37 : 745-751
 
P.78 掲載の参考文献
1) Goldberg RM, Tabah-Fisch I, Bleiberg H, et al : Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006 ; 24 : 4085-4091
 
2) Folprecht G, Seymour MT, Saltz L, et al : Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer : combined analysis of 2,691 patients in randomized controlled trials. J Clin Oncol 2008 ; 26 : 1443-1451
 
3) Scappaticci FA, Skillings JR, Holden SN, et al : Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natil Cancer Inst 2007 ; 99 : 1232-1239
 
4) Kozloff MF, Berlin J, Flynn PJ, et al : Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy : results from the BRiTE observational cohort study. Oncology 2010 ; 78 : 329-339
 
5) Matsuda T, Marugame T, Kamo K, et al : Cancer incidence and incidence rates in Japan in 2003 : based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2009 ; 39 : 850-858
 

4. 画像診断

P.82 掲載の参考文献
1) 桑鶴良平 : 肝転移の画像診断-Gd-EOB-DTPA MRIを中心に-. 癌と化学療法 2009 ; 36 : 1234-1241
 
2) Niekel MC, Bipat S, Stoker J : Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT : a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010 ; 257 : 674-684
 
P.85 掲載の参考文献
1) Johnson CD, Chen MH, Toledano AY, et al : Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008 ; 359 : 1207-1217
 
P.89 掲載の参考文献
1) 盛口佳宏, 上原圭介, 森谷宜皓, 他 : Linear staplerによるfunctional end-to end anastomosis後に吻合部再発をきたした結腸癌の2例. 臨外 2006 ; 61 : 1283-1286
 
2) Israel O, Yefremov N, Bar-Shalom R, et al : PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake : incidence, localization patterns, and clinical significance. J Nucl Med 2005 ; 46 : 758-762
 
3) Wiering B, Krabbe PF, Jager GJ, et al : The impact of fluoro-18-deoxygulcose-positron emission tomography in the management of colorectal liver metastases. A systematic review and metaanalysis. Cancer 2005 ; 104 : 2658-2670
 
4) Votrubova J, Belohlavek O, Jaruskova M, et al : The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2006 ; 33 : 779-784
 
5) Huebner RH, Park KC, Shepherd JE, et al : A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000 ; 41 : 1177-1189
 
P.93 掲載の参考文献
1) Renehan AG, Egger M, Saunders MP, et al : Mechanisms of improved survival from intensive followup in colorectal cancer : a hypothesis. Br J Cancer 2005 ; 92 : 430-433
 
2) Jeffery GM, Hickey BE, Hider P : Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002 ; 1 : CD002200
PubMed
3) Sobhani I, Tiret E, Lebtahi R, et al : Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 2008 ; 98 : 875-880
 

書評

最近チェックした商品履歴

Loading...